These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38362727)

  • 41. A Case of Nephrotic Syndrome With Minimal-Change Disease and Waldenstrom's Macroglobulinemia.
    Grabe DW; Li B; Haqqie SS
    J Clin Med Res; 2013 Dec; 5(6):481-3. PubMed ID: 24171061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.
    Al-Katib AM; Mensah-Osman E; Aboukameel A; Mohammad R
    Semin Oncol; 2003 Apr; 30(2):313-7. PubMed ID: 12720160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria.
    Treon SP; Tedeschi A; San-Miguel J; Garcia-Sanz R; Anderson KC; Kimby E; Minnema MC; Benevolo G; Qiu L; Yi S; Terpos E; Tam CS; Castillo JJ; Morel P; Dimopoulos M; Owen RG
    Semin Hematol; 2023 Mar; 60(2):97-106. PubMed ID: 37173155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. With M-protein positive, could transthyretin amyloidosis be easily excluded? Not necessarily! Wild-type transthyretin amyloidosis with Waldenström's macroglobulinaemia: a case report.
    Kinoshita H; Sugino H; Ishikawa A; Kido M; Kanegawa M; Kashiwabara A; Sumimoto Y; Masada K; Shimonaga T; Oka T
    Eur Heart J Case Rep; 2022 Nov; 6(11):ytac414. PubMed ID: 36339457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in the biology and treatment of Waldenström's macroglobulinemia: a report from the 5th International Workshop on Waldenström's Macroglobulinemia, Stockholm, Sweden.
    Treon SP; Patterson CJ; Kimby E; Stone MJ
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):10-5. PubMed ID: 19362961
    [No Abstract]   [Full Text] [Related]  

  • 46. Distal Tibia and Foot Involvement in a Patient With Waldenstrom's Macroglobulinemia.
    Priyanka P; Mercier R; Raiker R; Potugari B
    WMJ; 2018 Jun; 117(2):88-91. PubMed ID: 30048579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.
    Dimopoulos M; Gika D; Zervas K; Kyrtsonis M; Symeonidis A; Anagnostopoulos A; Bourantas K; Matsouka C; Pangalis G
    Leuk Lymphoma; 2004 Sep; 45(9):1809-13. PubMed ID: 15223640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ophthalmic tumor formation in Waldenström's macroglobulinemia.
    Terasaki H; Kikuchi S; Hoshi S
    Jpn J Ophthalmol; 1996; 40(3):385-9. PubMed ID: 8988429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells.
    Meyer S; Hafner C; Guba M; Flegel S; Geissler EK; Becker B; Koehl GE; Orsó E; Landthaler M; Vogt T
    Int J Oncol; 2005 Nov; 27(5):1197-206. PubMed ID: 16211213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bilateral central retinal vein occlusion in Waldenström's macroglobulinemia.
    Avashia JH; Fath DF
    J Am Optom Assoc; 1989 Sep; 60(9):657-8. PubMed ID: 2507620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Waldenström's macroglobulinemia and myasthenia gravis.
    Bartoloni C; Scoppetta C; Flamini G; Guidi L; Bartoccioni E; Lambiase M; Gambassi G; Terranova T
    J Clin Lab Immunol; 1981 Nov; 6(3):275-8. PubMed ID: 6802976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promiscuous and specific recognition among ephrins and Eph receptors.
    Dai D; Huang Q; Nussinov R; Ma B
    Biochim Biophys Acta; 2014 Oct; 1844(10):1729-40. PubMed ID: 25017878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IgM Myeloma: An IgM Gammopathy Distinct from Waldenstrom's Macroglobulinemia.
    Nordquist LT; Saba HI; Moscinski LC
    Hematology; 2001; 6(1):53-8. PubMed ID: 27419604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nephrotic syndrome and kidney failure due to immunocomplex-mediated renal damage in a patient with Waldenström's Macroglobulinemia: a case report.
    Castro H; Valenzuela R; Ruiz P; Lenz O; Monrroy M
    Cases J; 2008 Nov; 1(1):333. PubMed ID: 19019245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of anaplastic large cell (Ki-1) lymphoma of B-cell phenotype, occurring in Waldenström's macroglobulinemia.
    Hamada T; Ishizuka H; Asai Y; Yamazaki T; Sawada U; Hasegawa H; Uchida T
    Pathol Int; 1999 Oct; 49(10):913-7. PubMed ID: 10571827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
    Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
    Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung consolidation as a rare presentation of lymphoplasmacytic lymphoma with extramedullary Waldenström's macroglobulinemia.
    Abdulfattah O; Rahman EU; Bhattarai B; Dahal S; Alnafoosi Z; Trauber D; Enriquez D; Schmidt F
    J Community Hosp Intern Med Perspect; 2018; 8(2):68-72. PubMed ID: 29686791
    [No Abstract]   [Full Text] [Related]  

  • 58. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
    Amin CJ; Rabinowitz I
    Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mid-peripheral hemorrhages secondary to Waldenström's macroglobulinemia.
    Goen TM; Terry JE
    J Am Optom Assoc; 1986 Feb; 57(2):109-12. PubMed ID: 3081619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting cell adhesion and homing as strategy to cure Waldenström's macroglobulinemia.
    Pals ST; Kersten MJ; Spaargaren M
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):161-168. PubMed ID: 27825462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.